Evidence mapPaperPMID 37544768Full record

ArticleAddiction (Abingdon, England)2023

How to interpret studies on the impact of legalizing cannabis.

Jakob Manthey, Michael J Armstrong, Tobias Hayer, Daniel T Myran, Rosalie Liccardo Pacula, Rosario Queirolo, Jürgen Rehm, Marielle Wirth, Frank Zobel

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jakob MantheyCentre of Interdisciplinary Addiction Research (ZIS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID 0000-0003-1231-3760
Michael J ArmstrongDepartment of Finance, Operations and Information Systems, Brock University, St Catharines, Canada.
Tobias HayerInstitute of Public Health and Nursing Research, Department for Health and Society, University of Bremen, Bremen, Germany.
Daniel T MyranBruyère Research Institute, Ottawa, Canada.
Rosalie Liccardo PaculaPrice School of Public Policy and Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, California, Los Angeles, USA.ORCID 0000-0002-6145-9865
Rosario QueiroloDepartment of Social Sciences, Universidad Católica del Uruguay, Montevideo, Uruguay.ORCID 0000-0002-4385-8045
Jürgen RehmInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.ORCID 0000-0001-5665-0385
Marielle WirthDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Frank ZobelAddiction Suisse, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabisHallucinogensMarijuana SmokingMedical MarijuanaCanadaHumansLegislation, DrugHallucinogensMedical MarijuanaCanadacannabiscausalitycommercializationlegalizationpolicy

Identifiers

PMID37544768

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.